This report from GlobalData will help you better understand the potential impact of Trump 2.0 on the Automotive industry.

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

GlobalData (GB:DATA) has released an update. GlobalData Plc has executed a share buyback, purchasing 100,000 of its ordinary ...

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

Slowing electric-vehicle adoption is likely to accelerate even further as President-elect Donald Trump delivers on his ...

GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, ...

With Donald Trump securing his return to the White House for a second term, we explore what his second term could mean for ...

The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...

Demis Hassabis, joint winner of the Nobel Prize in Chemistry 2024, shared insights on AI at the FT Pharma and Biotech Summit.

GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, yet ethical and regulatory challenges persist. These tests raise concerns ...

Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.

A previous version of this article incorrectly said that U.S. restaurant spending is expected to reach $1.22 billion in 2024, ...